HYB0 Stock Overview
A med-tech company, provides high-tech and medical products worldwide.
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 3/6 |
| Past Performance | 4/6 |
| Financial Health | 5/6 |
| Dividends | 0/6 |
Rewards
Risk Analysis
No risks detected for HYB0 from our risk checks.
HOYA Corporation Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥111.00 |
| 52 Week High | JP¥121.00 |
| 52 Week Low | JP¥88.00 |
| Beta | 0 |
| 1 Month Change | 4.72% |
| 3 Month Change | -1.77% |
| 1 Year Change | 2.78% |
| 3 Year Change | n/a |
| 5 Year Change | n/a |
| Change since IPO | -17.21% |
Recent News & Updates
Recent updates
Shareholder Returns
| HYB0 | DE Medical Equipment | DE Market | |
|---|---|---|---|
| 7D | 4.7% | 0.8% | -0.4% |
| 1Y | 2.8% | -3.6% | 4.2% |
Return vs Industry: HYB0 exceeded the German Medical Equipment industry which returned -0% over the past year.
Return vs Market: HYB0 underperformed the German Market which returned 5.4% over the past year.
Price Volatility
| HYB0 volatility | |
|---|---|
| HYB0 Average Weekly Movement | 4.7% |
| Medical Equipment Industry Average Movement | 4.5% |
| Market Average Movement | 5.0% |
| 10% most volatile stocks in DE Market | 10.4% |
| 10% least volatile stocks in DE Market | 2.5% |
Stable Share Price: HYB0 has not had significant price volatility in the past 3 months.
Volatility Over Time: HYB0's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1941 | 36,571 | Eiichiro Ikeda | www.hoya.com |
HOYA Corporation, a med-tech company, provides high-tech and medical products worldwide. It operates through three segments: Life Care, Telecommunication, and Other. The company offers life care products, including eyeglass and contact lenses; medical endoscopes; intraocular lenses; laparoscopic surgical instruments; automatic endoscope cleaning equipment; and other medical related products, such as prosthetic ceramic fillers and metallic implants for orthopedics.
HOYA Corporation Fundamentals Summary
| HYB0 fundamental statistics | |
|---|---|
| Market cap | €39.24b |
| Earnings (TTM) | €1.07b |
| Revenue (TTM) | €4.51b |
36.6x
P/E Ratio8.7x
P/S RatioIs HYB0 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| HYB0 income statement (TTM) | |
|---|---|
| Revenue | JP¥762.61b |
| Cost of Revenue | JP¥340.92b |
| Gross Profit | JP¥421.69b |
| Other Expenses | JP¥240.32b |
| Earnings | JP¥181.38b |
Last Reported Earnings
Mar 31, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 517.45 |
| Gross Margin | 55.30% |
| Net Profit Margin | 23.78% |
| Debt/Equity Ratio | 3.0% |
How did HYB0 perform over the long term?
See historical performance and comparison